开云app官网登录入口网页版-官方正版

#EPOCH#

12篇内容 | 1222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2182844, encodeId=f1fa218284416, content=<a href='/topic/show?id=029d42e9060' target=_blank style='color:#2F92EE;'>#外周T细胞淋巴瘤#</a> <a href='/topic/show?id=30fc1282896' target=_blank style='color:#2F92EE;'>#Nivolumab#</a> <a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Nivolumab联合剂量调整EPOCH一线治疗外周T细胞淋巴瘤：一项I期研究, objectType=article, longId=809530, objectId=75c780953086, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=75c780953086, replyNumber=0, likeNumber=77, createdTime=2024-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=75c780953086, moduleTitle=Nivolumab联合剂量调整EPOCH一线治疗外周T细胞淋巴瘤：一项I期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=75c780953086)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1643088, encodeId=c8db1643088d5, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Blood：维奈托克联合R-EPOCH方案治疗Richter综合征, objectType=article, longId=295763, objectId=e956295e6364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e956295e6364, replyNumber=0, likeNumber=83, createdTime=2022-12-03, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e956295e6364, moduleTitle=Blood：维奈托克联合R-EPOCH方案治疗Richter综合征, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e956295e6364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643087, encodeId=a03e164308e6a, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后, objectType=article, longId=217929, objectId=39e621e9297d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39e621e9297d, replyNumber=0, likeNumber=92, createdTime=2022-03-14, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39e621e9297d, moduleTitle=J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=39e621e9297d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643085, encodeId=4d8d164308548, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Blood：EPOCH联合vorinostat治疗HIV相关非霍奇金淋巴瘤的疗效, objectType=article, longId=194559, objectId=330d19455981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=330d19455981, replyNumber=0, likeNumber=58, createdTime=2020-08-22, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=330d19455981, moduleTitle=Blood：EPOCH联合vorinostat治疗HIV相关非霍奇金淋巴瘤的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=330d19455981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643084, encodeId=cfd11643084cf, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Diabetologia：子宫内营养过剩对子代肥胖的持续影响:探索儿童围产期结局(EPOCH)研究, objectType=article, longId=185157, objectId=3b1818515eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1818515eff, replyNumber=0, likeNumber=72, createdTime=2020-05-07, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1818515eff, moduleTitle=Diabetologia：子宫内营养过剩对子代肥胖的持续影响:探索儿童围产期结局(EPOCH)研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3b1818515eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643086, encodeId=4e1b1643086a5, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Blood：Myc对采用EPOCH±Vorinostat治疗的HIV-NHLs的预后的影响, objectType=article, longId=195143, objectId=8218195143f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8218195143f1, replyNumber=0, likeNumber=72, createdTime=2020-12-19, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8218195143f1, moduleTitle=Blood：Myc对采用EPOCH±Vorinostat治疗的HIV-NHLs的预后的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8218195143f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643083, encodeId=69fe1643083be, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=77, createdTime=2019-04-07, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643080, encodeId=74e6164308094, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, objectType=article, longId=130749, objectId=b8ba130e490e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ba130e490e, replyNumber=0, likeNumber=82, createdTime=2018-11-18, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ba130e490e, moduleTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b8ba130e490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643082, encodeId=8c9116430828c, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, objectType=article, longId=144543, objectId=35051445433e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35051445433e, replyNumber=0, likeNumber=91, createdTime=2018-11-06, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35051445433e, moduleTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=35051445433e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643081, encodeId=7391164308152, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=0, createdTime=2018-06-20, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643079, encodeId=c1c016430e9fa, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, objectType=article, longId=119137, objectId=94bf11913e4a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94bf11913e4a, replyNumber=0, likeNumber=64, createdTime=2018-04-13, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94bf11913e4a, moduleTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=94bf11913e4a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643078, encodeId=684c16430e8a5, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=NEJM：低强度EPOCH -R方案可有效治疗免疫缺陷伯基特淋巴瘤成人患者, objectType=article, longId=26994, objectId=84d826994ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d826994ac, replyNumber=0, likeNumber=73, createdTime=2014-07-03, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d826994ac, moduleTitle=NEJM：低强度EPOCH -R方案可有效治疗免疫缺陷伯基特淋巴瘤成人患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=84d826994ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, objectTitle=JCEM：青春期前肌细胞内脂质沉积与代谢疾病风险相关（EPOCH研究）, objectType=article, longId=5717, objectId=786f5e1756, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=786f5e1756, replyNumber=0, likeNumber=66, createdTime=2012-08-05, rootId=0, userName=okhuali, userId=113323104213, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=786f5e1756, moduleTitle=JCEM：青春期前肌细胞内脂质沉积与代谢疾病风险相关（EPOCH研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=786f5e1756)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

EPOCH

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#外周T细胞淋巴瘤# #Nivolumab# #EPOCH#

Nivolumab联合剂量调整EPOCH一线治疗外周T细胞淋巴瘤：一项I期研究

2024-01-20发表于陕西省

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Blood：维奈托克联合R-EPOCH方案治疗Richter综合征

2022-12-03

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后

2022-03-14

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Blood：EPOCH联合vorinostat治疗HIV相关非霍奇金淋巴瘤的疗效

2020-08-22

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Diabetologia：子宫内营养过剩对子代肥胖的持续影响:探索儿童围产期结局(EPOCH)研究

2020-05-07

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Blood：Myc对采用EPOCH±Vorinostat治疗的HIV-NHLs的预后的影响

2020-12-19

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-04-07

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？

2018-11-18

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH

2018-11-06

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2018-06-20

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？

2018-04-13

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

NEJM：低强度EPOCH -R方案可有效治疗免疫缺陷伯基特淋巴瘤成人患者

2014-07-03

okhuali (审核中...)

前往app查看评论内容

#EPOCH#

JCEM：青春期前肌细胞内脂质沉积与代谢疾病风险相关（EPOCH研究）

2012-08-05

科室
- - 订阅+
  - 更多科室
工具
服务